These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2253 related items for PubMed ID: 29126301
1. Coagulation Testing in the Core Laboratory. Winter WE, Flax SD, Harris NS. Lab Med; 2017 Nov 08; 48(4):295-313. PubMed ID: 29126301 [Abstract] [Full Text] [Related]
2. Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study. Testa S, Legnani C, Tripodi A, Paoletti O, Pengo V, Abbate R, Bassi L, Carraro P, Cini M, Paniccia R, Poli D, Palareti G. J Thromb Haemost; 2016 Nov 08; 14(11):2194-2201. PubMed ID: 27566988 [Abstract] [Full Text] [Related]
7. Point-of-care coagulation testing for assessment of the pharmacodynamic anticoagulant effect of direct oral anticoagulant. Mani H, Herth N, Kasper A, Wendt T, Schuettfort G, Weil Y, Pfeilschifter W, Linnemann B, Herrmann E, Lindhoff-Last E. Ther Drug Monit; 2014 Oct 08; 36(5):624-31. PubMed ID: 24577124 [Abstract] [Full Text] [Related]
10. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants. Ząbczyk M, Kopytek M, Natorska J, Undas A. Clin Chem Lab Med; 2019 Aug 27; 57(9):1374-1381. PubMed ID: 30763261 [Abstract] [Full Text] [Related]
11. In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux. Samama MM, Mendell J, Guinet C, Le Flem L, Kunitada S. Thromb Res; 2012 Apr 27; 129(4):e77-82. PubMed ID: 21851967 [Abstract] [Full Text] [Related]
12. The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples. Bonar R, Favaloro EJ, Mohammed S, Ahuja M, Pasalic L, Sioufi J, Marsden K. Pathology; 2016 Jan 27; 48(1):60-71. PubMed ID: 27020211 [Abstract] [Full Text] [Related]
13. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin. Wong PC, Jiang X. Thromb Haemost; 2010 Aug 27; 104(2):302-10. PubMed ID: 20589316 [Abstract] [Full Text] [Related]
14. A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma. Letertre LR, Gudmundsdottir BR, Francis CW, Gosselin RC, Skeppholm M, Malmstrom RE, Moll S, Hawes E, Francart S, Onundarson PT. J Thromb Haemost; 2016 May 27; 14(5):1043-53. PubMed ID: 26924677 [Abstract] [Full Text] [Related]
18. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences. Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, van de Velde A, van Vliet H. Semin Thromb Hemost; 2005 Nov 27; 31(5):577-601. PubMed ID: 16276467 [Abstract] [Full Text] [Related]